Assessing the effectiveness of antiretroviral adherence interventions - Using marginal structural models to replicate the findings of randomized controlled trials

被引:39
作者
Petersen, Maya L.
Wang, Yue
van der Laan, Mark J.
Bangsberg, David R.
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA
[2] San Francisco Gen Hosp, Epidemiol & Prevent Intervent Ctr, Div Infect Dis, San Francisco, CA USA
[3] Univ Calif San Francisco, San Francisco Gen Hosp, Posit Hlth Program, San Francisco, CA USA
关键词
causal inference; counterfactual; HIV; G-computation; inverse probability of treatment; randomized controlled trial;
D O I
10.1097/01.qai.0000248344.95135.8d
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Randomized controlled trials of interventions to improve adherence to antiretroviral medications are not always feasible. Marginal structural models (MSM) are a statistical methodology that aims to replicate the findings of randomized controlled trials using observational data. Under the assumption of no unmeasured confounders, 3 MSM estimators are available to estimate the causal effect of an intervention. Two of these estimators, G-computation and inverse probability of treatment weighted (IPTW), can be implemented using standard software. G-computation relies on fitting a multivariable regression of adherence on the intervention and confounders. Thus, it is related to the standard multivariable regression approach to estimating causal effects. In contrast, IPTW relies on fitting a multivariable logistic regression of the intervention on confounders. This article reviews the implementation of these methods, the assumptions underlying them, and interpretation of results. Findings are illustrated with a theoretic data example in which MSM are used to estimate the effect of a behavioral intervention on adherence to antiretroviral therapy.
引用
收藏
页码:S96 / S103
页数:8
相关论文
共 11 条
[1]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[2]   Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures [J].
Hernán, MA ;
Brumback, BA ;
Robins, JM .
STATISTICS IN MEDICINE, 2002, 21 (12) :1689-1709
[3]   Effect of a brief antiretroviral adherence intervention delivered by HIV care providers [J].
Milam, J ;
Richardson, JL ;
McCutchan, A ;
Stoyanoff, S ;
Weiss, J ;
Kemper, C ;
Larsen, RA ;
Hollander, H ;
Weismuller, P ;
Bolan, R .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (03) :356-363
[4]  
NEUGEBAUER R, 2002, U CALIFORNIA BERKELE
[5]   Impact of an adherence clinic on behavioral outcomes and virologic response in the treatment of HIV infection: A prospective, randomized, controlled pilot study [J].
Rathbun, RC ;
Farmer, KC ;
Stephens, JR ;
Lockhart, SM .
CLINICAL THERAPEUTICS, 2005, 27 (02) :199-209
[6]   Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients [J].
Rawlings, MK ;
Thompson, MA ;
Farthing, CF ;
Brown, LS ;
Racine, J ;
Scott, RC ;
Crawford, KH ;
Goodwin, SD ;
Tolson, JM ;
Williams, VC ;
Shaefer, MS .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (02) :174-183
[7]   A GRAPHICAL APPROACH TO THE IDENTIFICATION AND ESTIMATION OF CAUSAL PARAMETERS IN MORTALITY STUDIES WITH SUSTAINED EXPOSURE PERIODS [J].
ROBINS, J .
JOURNAL OF CHRONIC DISEASES, 1987, 40 :S139-S161
[8]  
Robins J. M., 2000, 1999 P AM STAT ASS A, P6
[9]   Marginal structural models and causal inference in epidemiology [J].
Robins, JM ;
Hernán, MA ;
Brumback, B .
EPIDEMIOLOGY, 2000, 11 (05) :550-560
[10]  
Robins JM., 1999, Statistical models in Epidemiology, the Environment, and Clinical Trials, DOI [10.1007/978-1-4612-1284-3_2, DOI 10.1007/978-1-4612-1284-3_2]